SCHEMBL18467672

SCHEMBL18467672

CC1OC(C(=O)Nc2ccc3ccccc3c2)CC12CCCCCCCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ USP2 O75604 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CYP1A2 P05177 5/20 0.46
▸ RECQL P46063 1/20 0.46
▸ RAB9A P51151 6/20 0.43
▸ NPC1 O15118 5/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ EPHX1 P07099 1/20 0.42
▸ MEN1 O00255 5/20 0.42
▸ KMT2A Q03164 5/20 0.42
▸ MAPT P10636 4/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ CYP2C19 P33261 4/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ CYP3A4 P08684 3/20 0.40
▸ CYP2D6 P10635 3/20 0.40
▸ CYP2C9 P11712 3/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ TP53 P04637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18467651 0.67 CYP1A2 (0.48) ALDH1A1USP2HPGDCYP1A2RECQL
SCHEMBL18598053 0.67 ALDH1A1 (0.45) ALDH1A1USP2HPGDCYP1A2RECQL
SCHEMBL20272283 0.67 ALDH1A1 (0.45) ALDH1A1USP2HPGDCYP1A2RECQL
SCHEMBL10089409 0.65 RAB9A (0.68) RAB9ANPC1SMN1; SMN2EPHX1MEN1
SCHEMBL19425317 0.65 ALDH1A1 (0.45) ALDH1A1USP2HPGDCYP1A2RECQL
SCHEMBL4613238 0.64 CYP1A2 (0.56) ALDH1A1CYP1A2RECQLRAB9ANPC1
SCHEMBL2096821 0.64 RAB9A (0.62) ALDH1A1HPGDCYP1A2RAB9ANPC1
SCHEMBL25478350 0.64 DEGS1 (0.68) ALDH1A1HPGDCYP1A2RAB9ANPC1
SCHEMBL3500248 0.64 KMT2A (0.65) ALDH1A1CYP1A2RECQLMEN1KMT2A
SCHEMBL1176635 0.63 MEN1 (0.69) ALDH1A1CYP1A2RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9562019-B2 Substituted pyridazines as EGFR and/or KRAS inhibitors SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2017-02-07 — — US disclosed
Send feedback